ESP Block vs Control for Pain Control Following Percutaneous Nephrolithotomy

Recruiting N/A Interventional Study
Nephrolithotomy, Percutaneous
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Other
Participants needed
128 (estimated)
Sponsor
University of Tennessee Medical Center · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The purpose of this study is to investigate the use of the erector spinae (ESP) block in reducing the morphine milligram equivalent (MME) consumption post percutaneous nephrolithotomy. Objectives: 1. \- Determine if there is a significant effect on post percutaneous nephrolithotomy MME consumption with the usage of an ESP block vs. saline control. 2. \- Determine if there is a significant effect …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adults, male and female greater than or equal to 18 years of age and undergoing non-emergent percutaneous nephrolithotomy Monday through Friday between the hours of 6:00AM and 4:00PM. * Female participants of childbearing potential will be required to provide a negative pregna…
Contacts

Jason Buehler, MD

865-305-9220

jbuehler@utmck.edu

CONTACT

Aimee Pehrson

865-305-5432

apehrson@utmck.edu

CONTACT